An Ideological And Horticultural Taint

Although I am not a user of medical cannabis, the current scandal (and it can only be termed a scandal) regarding dangerous and forbidden pesticide use by companies with the Health Canada seal of approval is instructive.

First, a recap of the situation is in order:

After a string of recent recalls by Mettrum Ltd., OrganiGram Inc. and Aurora Cannabis Inc. because of the presence of myclobutanil – a banned pesticide that produces hydrogen cyanide when heated – a number of patients told The Globe and Mail they don’t see how Health Canada can assure them the product can be trusted. Revelations that the government isn’t testing regularly to prove all companies aren’t using harmful chemicals have left consumers concerned for their health.

The real villain of the piece is our current 'new and improved' government, which seems quite content to follow the same practices set out by the former, much-despised neoliberal Harper government.

In a background briefing with The Globe and Mail, a senior Health Canada official acknowledged that even though the government prohibits the use of potentially harmful chemicals such as myclobutanil, – which is known to emit hydrogen cyanide when heated –the department has not been testing cannabis growers to ensure the 38 federally licensed companies were, in fact, not using it.

Instead, the regulator has been leaving it up to the growers to police themselves on the use of potentially harmful chemicals.[emhpasis added]

The rather naive justification for this betrayal of the people using pot for therapeutic reasons is unconvincing:

... we have not required licensed producers [LPs] to test for any unauthorized pesticides, nor have we been testing all LPs, and it is because we expect their companies to be pro-actively watching and taking the appropriate measures to ensure non-authorized products aren’t used.

Perhaps the most damning aspect of all of this is that when a recall of tainted product took place in December, Health Canada refused to reveal the reason: the discovery of myclobutanil.

We will soon be a year-and-a-half into our 'new' government's tenure, more than sufficient time to set new directions for all government bodies, but just as Revenue Canada has shown no particular appetite for chasing down offshore tax evaders, despite the revelations of The Panama Papers, Health Canada and undoubtedly many federal regulators are still hewing to the much-vaunted neoliberal tenet of belief: industry self-regulation.

A damning indictment, to be sure, both of the medical marijuana industry and the Trudeau government, which clearly has not yet met a free-market policy it doesn't like.

UPDATED: I'm Outraged Over Her Outrage

Playing to her party's base, Health Minister Rona Ambrose yesterday expressed "outrage" over the Supreme Court's unanimous decision to make it legal for medical marijuana users to ingest their pot in any manner they see fit, be it oils, tinctures, cookies, or brownies. Given her well-demonstrated ineptitude in ensuring that Health Canada protect the health of Canadians, (apparently preferring to protect the health of pharmaceuticals' profits), something about which I have written at length on this blog, the integrity of yesterday's partisan denunciation of the court's decision must surely be called into question:



In the interests, as they say, of full disclosure, I do have a personal interest in this subject. My wife, for the past few years, suffered intractable and debilitating pain, pain that was relieved neither by over-the-counter medications nor narcotic painkillers. Happily, after recent surgery, most of that pain should be a thing of the past. Her suffering, however, was a disillusioning revelation to both of us; we had always assumed that most pain could be managed as long as doctors were willing to prescribe the necessary amounts of medication. This is not the case.

While I cannot say for certain that medical pot would have provided the sought-after relief, (and truth be told, my wife did not ask her doctor if he would prescribe it), I became resentful over two things: the fact that her access to it would have depended upon her doctor's beliefs and values, and the fact that Health Canada forbade the ingestion of medical pot in all forms except its dried form, which must be smoked or vaporized. Owing to a lung condition that she has, my wife would thus have been unable to use it in that form. Until yesterday's ruling, she would have been deemed a criminal.

Rona Ambrose asserts that research needs to be done to back up anecdotal claims of pot's medicinal benefits. She is surely being disingenuous here, given that big pharma will not undertake costly research into a substance that they cannot patent, and U.S,. medical research is severely circumscribed due to cannabis being listing as a Schedule 1 drug, reserved for the most dangerous of substances, right up there with heroin. Legal access is therefore difficult to obtain. Fortunately, in some parts of the world, enlighted attitudes coupled with compassion mean research is ramping up.

Beyond its benefits for pain relief, there are many claims to its benefits in treating intractable epilepsy:



And some in the medical community are quite receptive to the possibilities. Click here to play the clip.


If you want to read more about the above program and one mother's tireless battle to legally bring in a tincture from Colorado to her home state of Virginia to treat her saughter, click here. or watch the full program upon which the above is excerpted here. I watched the program when it aired, a good piece of journalism that one would have to be pretty hard-hearted not to be moved by.

Rona Ambose's obduracy of spirit, evidenced in her denunciation of the Supreme Court decision, is unacceptable and a gross insult to all who seek wider access to a medicine that may help them. The Harper regime's shameful trumping of ideology over compassion has no place in the Canada I know and live.

UPDATE: Even if you lack the time or the inclination to watch the Dateline program I described above, go to the 28 minute mark where you will see a vet suffering from PTSD who moved to Coloradeo to have access to marijuana. He displays all of the medications he was prescribed, which he says made him feel like a zombie, that he was able to dispose of once he started using cannabis to treat his condition. It is a powerful visual of what is at stake for the pharmaceuticals and suggests why they are likely a powerful force against widening marijuana's use.

Health Canada Fails Us Yet Again

On this blog I have frequently extolled the fine investigative journalism practised by The Toronto Star. Whether on issues of municipal, provincial, or federal significance, The Star, as it frequently proclaims, "gets action."

From the standpoint of average Canadians, probably one of its most important investigations in recent times has been into Health Canada and its all too cozy relationship with the pharmaceutical industry, an industry protectorate seems to treat more as an equal than as an activity to be regulated. its relationship with the generic company Apotex is especially troubling.

Despite previous avowals by Health Minister Rona Ambrose that things would improve, it seems that business as usual prevails at Apotex. Yesterday, The Star reported that problems have again been uncovered, this time at its Brantford palant, information that, as in the past, comes not from Health Canada, but the U.S. Food and Drug Administration:

At the Brantford facility in November, FDA inspectors found the company launched an internal review in 2013 to ensure it was effectively cleaning the equipment used to make drug products. Three swab tests of the equipment found unacceptable levels of contamination.

But Apotex shelved its internal review “until (an) effective cleaning procedure is developed,” according to an Apotex memo reviewed by FDA inspectors.

Then, in September 2014, the company made multiple batches “using the same equipment cleaning methods that failed the cleaning validation,” FDA inspectors found.

The company then released the drug products “based on a less stringent” quality-control requirement.

What were the possible contaminants?

An industry expert said the most common contamination from improperly cleaned equipment would be bacteria or trace amounts of another drug or antibiotic made using the same machines.

So where was Health Canada in all of this?

The agency, which had conducted its own inspection in July with similar discoveries, tagged along with the FDA in its November inspection. But that's where common ground diverges. While the FDA made the result of the inspection publicly available, Health Canada says it is still finalizing the report from its July inspection.

A hard-hitting editorial in today's Star makes it abundantly clear that this kind of cavalier foot-dragging is unacceptable:

That’s not good enough. It’s January and drugs that could possibly be contaminated are on the market.

Health Canada must move a lot more quickly to ensure consumer safety. And it clearly needs to take a much more rigorous look into Apotex’s manufacturing practices. The company has a long history of safety issues at its plants.

The editorial ends with sentiments that few Canadians could disagree with:

In the end, consumers are dependent on Health Canada — not the FDA — to ensure that drugs on the Canadian market are safe and effective. Health Canada should immediately identify the drugs in question and issue its report on Apotex’s Brantford plant. And it needs to have a good hard look at all of Apotex’s manufacturing practices.

Consumer safety is at stake.

That, strangely enough, does not seem to be a priority with Health Canada.

My CBC Letter Of Complaint

Although probably a futile effort, here is the letter of complaint that I have sent to the CBC ombudsman, The National, and CBC Audience Feedback regarding the Corporation's absolute failure to keep Canadians informed about the Health Canada's unwillingness to protect Canadians from tainted pharmaceuticals:

To Whom It May Concern:

I am writing to complain about the abject failure of the CBC to inform Canadians on an issue that is a potential threat to both health and life. That issue recently emerged when The Toronto Star conducted an excellent investigative series into the lack of drug safety oversight being provided by Health Canada: http://www.thestar.com/search.html?q=apotex

The investigation revolved around the agency's failure to hold generic drug manufacture Apotex to account for issues that resulted in several of their drugs being banned by the American Food and Drug Administration, which maintains a publicly accessible database to keep its citizens informed over drug investigations, recalls, etc. Health Canada refused to make this information public; Health Minister Rona Ambrose cited 'proprietary privacy issues.'

The Star investigation also uncovered the fact that Health Canada asked Apotex to suspend the importation of certain drugs, and the company refused. Again, no details as to the suspect drugs were released to the public.

This matter was taken up in the House of Commons, and as a result of the efforts of both the NDP and The Star, action has finally been taken, as reported in today's edition: http://www.thestar.com/news/canada/2014/09/30/health_canada_bans_drugs_from_two_indian_factories.html

I am sure you would agree that this story is of national interest and significance. Yet as far as I can determine, on none of your platforms, be it radio, television, or Internet, has a word of this scandalous situation been uttered or printed.

This is behaviour totally unacceptable for Canada's national broadcaster.

I avidly await your explanation for this egregious failure to keep Canadians informed.

It's Why I Subscribe

To borrow a line from one of my favourite Shakespearean plays, Macbeth, "So fair and foul a day I have not seen."

It is fair because the newspaper I subscribe to and heartily endorse, The Toronto Star, has achieved a victory whose significance cannot be overestimated. Thanks to its investigative series into Health Canada's scandalous and potentially life-threatening negligence in overseeing drug safety, Health Minister Rona Ambrose, has finally acted:

Health Canada has banned the import of all drugs and drug ingredients made by two Apotex factories in Bangalore, India, with Health Minister Rona Ambrose saying Tuesday night that the trust between the regulator and the Toronto-based drug company has been “broken.”

Despite that action, long in coming, there are no plans to recall any of the 30 suspect drugs manufactured at the plants, drugs that include

a generic form of Viagra, the antibiotic azithromycin, and other drugs made to treat hypertension, dementia, high blood pressure, asthma, convulsions and Lou Gehrig’s disease.

Not surprisingly, the information that led to the decision was taken from the FDA database, which is fully transparent and accessible to the public.

So what is foul? Two things:

One, had it not been for the tenacity of The Star, Health Canada would have continued to give its imprimatur to potentially life-threatening drugs, thereby egregiously failing in one of the most important aspects of its mission.

Two, despite the significance of the scandal, and despite the fact that it provoked some intense questioning from the NDP in The House of Commons, no other media outlets reported the story to my knowledge, not even the CBC, our putative national broadcaster.

Why the silence? One can only speculate, but I do intend very soon to write a letter to the CBC to ascertain the reason. Some might link it to the Corporation's policy of appeasement, about which I have written previously.

I will let you know if I get any response from the CBC.

A Possible Soution To Health Canada's Willful Impotence

Yesterday I wrote about the fact that Health Canada has 'convinced' (not ordered) Apotex to stop importing drugs from one of its suspect plants in Bangalore, India. The agency's (and Health Minister Rona Ambrose's) ongoing timid relationship with pharmaceuticals at the expense of our health and safety suggests stronger measures are needed

Writing in The Star, Amir Attaran thinks he might have a solution to this sorry state of affairs. The professor in the Faculty of Law and faculty of Medicine at the University of Ottawa asks,

should we reduce, or nearly abolish, Health Canada’s drug regulatory functions? Could we be safer by trusting in the decisions of larger, better-funded, foreign drug regulators instead of little lame Health Canada?

He looks to Europe for a model:

The 28 countries of the European Union, many of them quite small, long ago decided that it is expensive, inefficient and sometimes dangerously ineffective for each country to have its own drug regulator. Nowadays, most of them have delegated large parts of their drug regulatory functions to an EU-wide organization, the European Medicines Agency.

Attaran is not optimistic that Canada will likely follow suit with a similar co-operative venture:

Here, the Harper government’s asphyxiating control of government scientists and almost childish pride in Canadian sovereignty mean that Health Canada minimally co-operates with America’s FDA just next door. This is dumb: the FDA is more transparent, better resourced and scientifically better equipped than Health Canada will ever be.

He goes on to offer a picture of the FDA's ruthless effectiveness in interdicting suspect drugs:

Consider the case of Ranbaxy, a pharmaceutical company from India. Last year, the FDA successfully prosecuted Ranbaxy for manufacturing adulterated drugs and misleading it with false, fictitious and fraudulent drug testing data — crimes for which Ranbaxy paid $500 million (U.S.) in criminal and civil penalties.

Contrast that decisiveness with Health Canada's feckless dealings with the same company:

Even though former Ranbaxy executives say they are “confident there were problems” with drugs sold here, after the criminal conviction Health Canada refused to ban Ranbaxy’s factories, and instead negotiated with the company to voluntarily pull a few of its medicines off the market for testing; Health Canada won’t say which ones.

According to Attaran, the main reason for this gross disparity of response is not legal, but cultural,

namely the indolent, lapdog attitude of ministers like Ambrose and the public servants at Health Canada, who seem to lack any understanding of how governments should regulate.

Because they refuse to learn from the best practices of bodies like the FDA and the European Medicines Agency, he concludes that

we should in part abolish Health Canada and harmonize our drug regulation with those foreign agencies that are more competent than our own government.

While that might strike many as too drastic a solution, it is clear that major changes are needed if we are to be protected from corrupt and venal pharmaceutical companies that place their profits and their shareholders above the health and safety of Canadians.

Health Canada's Willful Impotence on Tainted Pharmaceuticals

As I have written previously, the scandal of tainted pharmaceuticals continues, and that which should provoke outrage and demands for accountability seems to elicit for the most part only shrugs and mild interest. And were it not for the Toronto Star's ongoing quest, most of us would be totally unaware of the threats to our health that are aided and abetted by Health Canada and Health Minister Rona Ambrose, thanks to a larger media, including the CBC, that have given the scandal absolutely no coverage.

Despite the investigative series conducted by the paper and an excoriating editorial, the only action thus far taken by Health Minister Rona Ambrose and her recalcitrant department has been to 'convince' (not order) Apotex to

stop distribution to Canadian retailers of what Health Minister Rona Ambrose described as “all products” manufactured at one of Apotex’s factories in Bangalore, India.

“The quarantine will allow the department time to verify that products from this facility meet Canadian safety and quality requirements,” Health Canada said in a short release.

I guess that is progress of sorts, since the last time Health Canada made such a request, Apotex refused. However, it is an anemic response given that when the issue first arose, the FDA banned the suspect drugs from entering the U.S.

However, even in Health Canada's putative victory with Apotex, there is less here than meets the eye, as is typical of the Harper regime:

Health Canada has not told the public what drugs are affected by this quarantine.

So even though many Canadians will have been taking these suspect and tainted drugs, they are not permitted to know which ones they are. Undoubtedly, as has been previously discussed, in the warped of Ambrose and her department, that information is considered commercially confidential.

In my next post, I'll discuss a possible way around the protective wall of silence erected by Health Canada to protect the pharmaceutical industry.

Pros and Cons

Following up on Rona Ambrose's stout denial that the government's planned anti-marijuana campaign has anything to do with trying to undermine Justin Trudeau, along with Canadian doctors refusing to be part of a campaign that has become, as they describe it, political messaging, here are the perspectives of two National Post readers:

Re: Health Canada Doesn’t Endorse Medical Use Of Pot, Ambrose Says, Aug. 19.

The time for legalizing marijuana is long overdue. It strikes as more than a little hypocritical that the politicians in this country spend our tax dollars to bewail the evils of pot, while alcohol is given a free pass on being socially acceptable.

It would be interesting to compare the harms caused by alcohol and marijuana. Should we start with tallying vehicular injury and death? Then we could calculate which substance contributes more to violent crime. Then look at which is more likely to cause social ills, such as broken families and spousal abuse. Then we could also measure the medical costs incurred on the health system by both substances.

Every state in the U.S. that has fully legalized marijuana has reported only positive results — socially and economically. It is time that the politicians and the people benefiting from this draconian system of prohibition accept the facts.

Robert Fitzpatrick, Sicamous B.C.

Playing politics

By refusing to take part in a Health Canada anti-drug campaign that will target young people, the doctors are showing their political bias in favour of Liberal leader Justin Trudeau, who supports legalizing marijuana use. Can’t they see that they have allowed their politics to prevent their informed opinion on discouraging marijuana use to be propagated?

Jiti Khanna, Vancouver.

Denial And Outrage

During my teaching career, it was occasionally my unpleasant task to confront a student with evidence of his or her cheating; most situations revolved around plagiarizing essays or having skipped a test. The student's responses when confronted were invariably the same; indeed, they tended to parallel Elizabeth Kubler-Ross' five stages of grief.

I won't bore you with the details, but common initial reactions were denial that any offence had occurred, ("I have no idea what you are talking about"), and when that failed, anger that I would harbour such unfounded and unworthy suspicions ("I am really hurt that you would accuse me of such a thing"). Invariably, they were guilty as charged.

There seems to be an analogous system at work in politics.

Let's start with the Harper regime's upcoming campaign against marijuana use, the one that the three main groups representing doctors, Family Physicians of Canada (CFPC), Canadian Medical Association (CMA) and the Royal College of Physicians and Surgeons of Canada have refused to be part of because they "... do not, support or endorse any political messaging or political advertising on this issue".

The accusation that the campaign has become a political football aimed at discrediting Justin Trudeau, who favours legalization of pot, has been hotly denied by Health Minister Rona Ambrose:

“Telling kids to not smoke pot is not a partisan attack on Justin Trudeau by Health Canada,” Ambrose told a news conference Monday on the sidelines of the annual Canadian Medical Association meeting.

“It is a sound public health policy backed by science. Whether pot is legal or illegal, the health risks of marijuana to youth remain the same, and we should all be concerned about them.”

She added that Trudeau “made this a political issue.”

Denial and shifting the blame, both time-honoured tactics of my former wayward students.

Next, the anger:

This morning's Star reports the following:

The federal New Democrats are hoping to put the Canada Revenue Agency under the microscope Tuesday after recalling a House of Commons committee to examine a wave of audits against registered charities.

NDP MP and revenue critic Murray Rankin (Victoria) has questioned whether the audits were politically motivated actions against those advocating for environmental causes and other issues clashing with the Harper government’s policies.

However, Revenue Minister Kerry-Lynne Findlay rejects the allegations, and with great umbrage:

“Your baseless allegation that I have used my office to blatantly misappropriate CRA resources to target and intimidate charities that don’t agree with our government’s policies is absolutely reprehensible,” wrote Findlay in a letter to Rankin, dated Aug. 5.

“As an honourable parliamentarian, I find your unwarranted attacks on the integrity of the CRA and my office shameful and plunges parliamentary discourses to new lows.”

To quote from my favourite Shakespearean play, "The lady doth protest too much, methinks." Such indignation may play well to the party's base, but critical thinkers may wonder at the rhetorical flourishes employed by Ms. Findlay here.

The final stage in the five stages of grief is acceptance. For the Harper regime, I suspect that will only come after the results of the next election.

Slamming Harper Secrecy

The Toronto Star recently revealed the following:

Health Canada is keeping secret the vast majority of the drug reviews it conducts despite a clear promise from the federal minister to publish this critical safety information.

Only 24 of 152 drug reviews completed last year by Health Canada are being considered for public release, the Toronto Star has learned. The drug safety reviews that will be open to the public are those triggered by alarms raised by foreign regulators, medical or scientific literature or Health Canada’s routine monitoring activities.

The main reason? Wholly consistent with the Harper regime's legendary secrecy and the preeminence it accords to all things corporate, is this justification:

The information is classified in part because it was provided “with the understanding that this information is proprietary,” a Health Canada spokeswoman told the Star in an email Wednesday.

In layperson's language, corporate concerns trump citizen safety. Aided and abetted by Health Canada, safety information falls under the rubric of commercial secrets - this despite some well-publicized tragedies that might very well have been avoided had the public had access to vital information about toxicity studies and drug side effects.

As usual, perspicacious Star letter-writers offer their views of this intolerable insult to all who believe that the free flow of information is one of the crucial elements of a healthy democracy:


Ottawa keeps drug reviews under wraps, April 12

The Canadian public is once again being “stonewalled” by the Harper government. The reason that I am calling this the “Harper Government” is the fact that Stephen Harper runs this government like a dictatorship. His ministers are muzzled until Harper approves of what statements they are allowed to make to the media.

He arbitrarily releases information only when he feels like doing so, not when the public has a genuine need to know the details of situations, such as rail safety measures put in place after the disaster in Quebec, and now the federal drug reviews of 151 various medications.
According to Dr. David Juurlink from Sunnybrook Hospital, “These drugs harm people and in some instances they kill people. Frankly, shame on (Ottawa) for even contemplating not publishing them.” The doctor doesn’t realize that in Ottawa there is no shame, only secrecy.

Why all of this secrecy when Ottawa has supposedly made a commitment to being more transparent? This government is as “transparent” as the heavily tinted windows in a motor vehicle.

In 1947, there was a movie starring Danny Kaye, The Secret Life of Walter Mitty. This movie was re-made in 2013 with Ben Stiller as the star. In Canada, it could have been made as The Secret Life of Stephen Harper, starring our Prime Minister.

Also, Harper would have been the perfect guest on the 1950s and 1960s TV show I’ve Got A Secret. He has so many secrets that the panel would never guess to which one he was referring.

Warren Dalton, Scarborough


The reason Ottawa keeps drug reviews under wraps is the same reason Transport Canada keeps under wraps the movement of toxic materials through highly populated areas. The “conservative corporate party” in Ottawa is not about to bite the hand that feeds it. Ask yourself: who is damaged by disclosure?

Nicholas Kostiak, Tottenham


Drugs that have been developed under the sole funding of the private sector may, indeed, legitimize claims to exclusive rights to such information. Where the public has funded the research and development of pharmaceuticals, however, the public has a right to the results of such research.

Canadian taxpayers have contributed billions of dollars, under a multitude of programs, to the development of pharmaceuticals. We seem to have forgotten Harper’s Economic Action Plan and the Canada Foundation for Innovation, which funnelled hundreds of millions of dollars to the research and development of pharmaceuticals in the year 2009 alone. If you follow the money, you’ll discover that the public has just as many proprietary rights to the much-guarded research.

Those who wish to have exclusive rights to research results, data, analyses, outcomes or reports should also ensure their exclusive funding of such research activity rather than looking to the public purse for support. Until then, we have a right to know exactly what our money has produced.

Stella Kargiannakis, Toronto

A Debt Owed To The Media

As fashionable as it is to denigrate the mainstream media for their frequent timidity and conservatism, public knowledge about both Rob Ford's disgraceful performance as Mayor of Toronto and the current Senate scandal embroiling Stephen Harper, impeaching the integrity and honesty of both politicians, would not exist were it not for a diligent media, especially the press.

I have often stated in this blog that I am both proud and pleased to subscribe to The Toronto Star, given the integrity of its work and the fact that many of its investigations have resulted in change at both the local and the national level. These changes have included rigorous restaurant inspections whose results are now publicly posted to its most recent accomplishment, a promise from Minister of Health Rona Ambrose to remediate the situation after The Star brought to light the tragic death of Marit McKenzie, killed by a blood clot caused by an acne medication. At the time, Health Canada said that the drug safety review information was classified due to "confidential business information."

Yesterday, during an interview about her role in exposing the video apparently showing Rob Ford smoking crack, Star reporter Robin Doolittle encouraged people to take out a subscription to a newspaper, the implication being that the work they do is crucial in a democracy, and that work cannot be accomplished without the financial support of engaged readers.

Were it not for the diligent work of CTV reporter Robert Fife, who was instrumental in exposing Senategate, followed up by the efforts by other dedicated reporters, a corrupt and disdainful Prime Minister would be able to spin his tales of fancy without challenge. Instead, Stephen Harper and his cabal face what is likely their greatest crisis, one that may very well reverberate until the next election and could even result in criminal charges.

Watergate may have set the standard for investigative journalism, but the need for curious reporters with a passion for the truth will extend far into the future. No, whether we acknowledge it or not, a healthy press is a linchpin of a healthy democracy, augmented by social media and blogs, no doubt, but never to be replaced by them.

To reiterate Doolittle's message, "Get a newspaper subscription." The health of our political system may very well depend on you.

Who Do You Trust?

Two seeming unrelated stories, both connected by one pernicious element: unwarranted government secrecy.

In this morning's Hamilton Spectator is the sad tale of Marit McKenzie, an 18-year-old Calgarian who died after taking an anti-acne drug known as Diane-35. Often prescribed off-label as a birth-control pill, the drug's side effects can include formation of blood clots, a contingency that led to the girls's death.

Bruce McKenzie would like to know how a controversial acne drug suspected of killing his healthy teenage daughter this year has, in Health Canada's words, "benefits" that "continue to outweigh the risks."

But the report that could explain how the federal agency arrived at this conclusion is a secret. It's one of more than 150 classified safety reviews completed by Health Canada this year alone.

Despite the fact that France has banned the drug, and despite the fact that even the bastion of free enterprise, the U.S., along with the European Medicines Agency, routinely publish details of post-market safety reviews of drugs as a basic accountability measure, Health Canada refuses to provide any details about its alleged efficacy. The reason? According to our government, it is due to "confidential business information."

The implications of this stance are indeed frightening for anyone in Canada on long-term medication, given that the current database for adverse reactions is simply based on voluntary reports from doctors and patients. But at least the health of our pharmaceutical industry will be protected, the obvious priority with the Haper cabal.

On a similar, though ostensibly unrelated corporate note, is the CETA agreement that Stephen Harper is crowing about. Will it be a net benefit or a net detractor of Canadian jobs? Will it be an impediment to environmental protection and other matters crucial to our sovereignty? Who knows? As Tim Harper points out in today's Star,

But no one can say that definitively right now ...This was an agreement in principle, but there was no fine print.

Despite Harper's claim that these negotiations were the most “transparent and inclusive in Canada’s history”, the truth is that they have carried out in a cloak of secrecy that perhaps rivals that which shrouded the development of the atomic bomb. Secrecy, that is, for everyone but business groups who have been in a position to dictate their demands for quite some time.

And as for Harper's promise that affected sectors will be compensated for any losses, such as the probable $2 billion extra that the provinces will have to come up with due to increased drug costs thanks to another gift to the pharmaceuticals, a two-year patent extension on drugs, I leave that to the overly credulous to believe.

Who do you trust? Not this government, and not this Prime Minister who has proven countless times that truth and honesty are merely quaint notions that sound nice on paper, but have little to do with the debased elements by which he operates.

Medical Marijuana - Part 2

The other day I wrote a post suggesting that policy formulation in the Harper government is conducted not in the measured and studied way most governments employ, but rather more than anything else from a knee-jerk ideological orientation. This is apparent most recently in Health Canada's decision to license private farms to grow medical marijuana, thereby ending the legal right of current licensed users to grow and buy their own. It turns out that the cost of purchasing the product from these private farms, beginning in March of next year, will be more than many can afford.

A discerning reader, Glenda Allard Barr, from Lantzville, B.C., writes the following in this morning's Star:

New pot rules sting ailing users, Column, Feb. 1

Thank you for printing this outstanding glimpse into the world of ailing Canadians who are terrified that they will lose the quality of life they have gained by having access to an extremely effective plant medicine. Serious health problems often result in an inability to earn a good living, and the new medical cannabis program proposed by Health Canada would serve to line the pockets of business people while depriving the sick of their medicine.

Anyone with a heart should be able to see the difficulties faced by these patients, and the benefits they gain from using a plant that is safer than most, if not all, pharmaceuticals. The ability to grow one's own medicine or to find a compassionate person to grow for them can be a life saver for some seriously ill individuals.

The black market also stands to gain from this proposal as purchasing cannabis from commercial sources is beyond the financial reach of patients, and will introduce new problems, such as having to wait for an order, delivery problems, specific strain availability, possible chemical contamination and irradiation. Some patients may turn to crime to fund their medicine.

Health Canada needs to fulfill its mandate to protect the health of Canadians. It is time to trash this preposterous proposal, take another look at past commissions studying cannabis use, and approach the issue in an enlightened and compassionate manner. In my mind, that solution is legalizing and regulating this useful plant.

Industry Self-Regulation - An Update

Yesterday I wrote a post about the plight of Ryan Harrington, the young man who, were it not for a drug called Celontin, would suffer upwards of 200 seizures a day. Because the Harper regime opted for a voluntary system instead of a law requiring companies to report drug shortages, Harrington had only a one-week supply of the drug left.

The Toronto Star today reports that his family has been able to secure a one-month supply of the drug from the U.S., no thanks to our government. Says Brigitte Harrington, Ryan's mother:

“It’s a band-aid” ... “We’ve applied another band-aid to the layer. We have not addressed the problem. We have not cleaned up the mess.”

Despite the shortage, Health Canada denied three separate applications from Harrington to acquire the drug from the U.S.

When asked why the first three requests were denied, Health Canada spokesperson Sara Lauer responded, “Initial requests … were not fulfilled because the manufacturer, ERFA, informed Health Canada the product would be on the market until December 2012 and it was working to avoid any potential back-order.”

I would like to think that our political 'leadership' has learned something from this episode, distressing in its wider implications, but experience suggests that in the battle between marketplace ideology, so beloved of the Harper regime, and the public good, we the people are pretty much on our own.

Industry 'Self-Regulation'

In a world rife with the environmental, economic and social consequences of unfettered capitalism, the term 'industry self-regulation' has always struck me as little more than a oxymoron. Examples abound of what happens when government regulatory agencies enter into what turn out to be Faustian bargains with the corporate sector, the sad case of XL Foods perhaps the one most prominent in recent memory.

Today's Star exposes yet another failure of corporate oversight as it reports on the plight of Ryan Harrington, a young man afflicted with a severe form of epilepsy that, without the proper medication, leads to upwards of 200 seizures a day. Unfortunately, he has just a seven-day supply left of the only drug that limits his episodes to three per day, Celontin. The blame for his plight must rest solely on the shoulders of Federal Health Minister Leona Aglukkaq and the ethos that her government embraces

Because she opted for voluntary instead of mandatory reporting of drug shortages by the pharmaceutical industry, Harrington faces his dire situation. This, despite the fact that Health Canada staff warned that a voluntary system would be “susceptible to bad company behaviour.”

Why is this failure to report the drug shortage so crucial in Harrington's situation? Had his family known, they could have applied for special access to the drug, which is still produced in the U.S.

As is so often the case today, it is the journalistic integrity of The Toronto Star that has brought this issue to the public's attention. A followup editorial, which I hope you will take time to read, makes a compelling case for mandatory reporting:

A comprehensive, up-to-date system providing early warning of drug shortages would give hospitals, doctors and provincial health ministries a head start on finding alternatives and developing strategies for coping with what's to come. Forewarned is forearmed. So it doesn't make sense from a public health perspective to give manufacturers a penalty-free choice on whether or not to comply.

Not something those ideologues possessed of 'terminal certitude', to borrow a phrase used by Owen over at Northern Reflections, may want to hear, but nonetheless a necessary measure for the rest of us.

Now This Really Is Funny

It is a rare occasion when I experience a good belly laugh, but the following bogus media release, reported by the CBC's Allison Crawford, had that effect. While I doubt that the morose and ostensibly humourless Harper government will be amused, those with a degree of normalcy in their mental and emotional makeup probably will. Enjoy:

Harper Government Announces New Fitness Tax Credits for Seniors Shovelling Snow

OTTAWA - The Hon. Leona Aglukkaq, Minister of Health and Minister of the Canadian Northern Economic Development Agency today announced a new Fitness Tax Credit for Seniors who shovel their own sidewalks, effective immediately.

Aglukkaq said that the new program is the first in a series of "preventive" health care measures from the Harper Government that will pare health care costs by encouraging Canadians to take greater responsibility for their health, while also supporting independent living and fitness in those 55 and over.

"Studies show that seniors can improve muscle mass and cardiovascular fitness through strenuous physical activity," said Aglukkaq. "By instituting a Seniors Fitness Tax Credit for Shoveling Snow, seniors on fixed incomes will not have to pay anyone to shovel their walks, they will be rewarded - even posthumously - for doing it themselves."

Aglukkaq said that seniors who mail in photographic or video proof that they shovel their own sidewalks will receive a crisp $50 Canadian bill in the mail. If the snow is heavy and wet, the amount rises to $100.

Concerns that shoveling snow might lead to heart attacks was unwarranted, said Aglukkaq.

"There is no scientific consensus on the link between shoveling snow and heart attacks," said Aglukkaq. "In fact, there is considerably more credible scientific evidence for climate change."

Aglukkaq said that if the program is widely adopted, it would actually save the government hundreds of millions of taxpayers' dollars by reducing overspending in CPP, the Guaranteed Income Supplement, and health care costs. The savings would be achieved mostly through attrition, she added.

-30-

Media Enquiries:


Health Canada

(613) 957-2983

Public Enquiries:

(613) 957-2991
1-866 225-0709